Virtus ETF Advisers’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,251
Closed -$344K 322
2024
Q4
$344K Buy
2,251
+843
+60% +$129K 0.14% 206
2024
Q3
$273K Hold
1,408
0.13% 237
2024
Q2
$326K Sell
1,408
-78
-5% -$18.1K 0.16% 215
2024
Q1
$320K Buy
1,486
+214
+17% +$46.1K 0.17% 222
2023
Q4
$329K Buy
1,272
+256
+25% +$66.2K 0.21% 207
2023
Q3
$261K Sell
1,016
-129
-11% -$33.2K 0.16% 221
2023
Q2
$326K Buy
1,145
+81
+8% +$23.1K 0.19% 179
2023
Q1
$296K Buy
1,064
+17
+2% +$4.73K 0.16% 225
2022
Q4
$290K Sell
1,047
-168
-14% -$46.5K 0.15% 285
2022
Q3
$324K Buy
1,215
+20
+2% +$5.33K 0.13% 267
2022
Q2
$244K Sell
1,195
-417
-26% -$85.1K 0.09% 305
2022
Q1
$339K Hold
1,612
0.15% 162
2021
Q4
$387K Buy
1,612
+481
+43% +$115K 0.15% 162
2021
Q3
$320K Sell
1,131
-98
-8% -$27.7K 0.14% 192
2021
Q2
$426K Sell
1,229
-1,321
-52% -$458K 0.18% 186
2021
Q1
$713K Buy
2,550
+68
+3% +$19K 0.3% 105
2020
Q4
$608K Buy
2,482
+389
+19% +$95.3K 0.25% 110
2020
Q3
$594K Buy
2,093
+121
+6% +$34.3K 0.31% 114
2020
Q2
$528K Sell
1,972
-45
-2% -$12K 0.25% 146
2020
Q1
$638K Sell
2,017
-205
-9% -$64.8K 0.26% 143
2019
Q4
$659K Sell
2,222
-948
-30% -$281K 0.11% 165
2019
Q3
$738K Sell
3,170
-386
-11% -$89.9K 0.15% 159
2019
Q2
$832K Buy
3,556
+1,180
+50% +$276K 0.18% 177
2019
Q1
$562K Buy
2,376
+467
+24% +$110K 1.2% 27
2018
Q4
$574K Sell
1,909
-652
-25% -$196K 0.1% 56
2018
Q3
$905K Buy
2,561
+173
+7% +$61.1K 0.09% 54
2018
Q2
$693K Sell
2,388
-438
-15% -$127K 0.61% 104
2018
Q1
$774K Sell
2,826
-164
-5% -$44.9K 0.67% 78
2017
Q4
$953K Sell
2,990
-1,095
-27% -$349K 1.2% 32
2017
Q3
$1.28M Hold
4,085
0.17% 45
2017
Q2
$1.11M Buy
4,085
+468
+13% +$127K 0.17% 47
2017
Q1
$989K Buy
3,617
+348
+11% +$95.2K 0.18% 69
2016
Q4
$927K Buy
3,269
+694
+27% +$197K 0.28% 65
2016
Q3
$806K Buy
2,575
+324
+14% +$101K 0.39% 43
2016
Q2
$544K Buy
2,251
+206
+10% +$49.8K 0.4% 41
2016
Q1
$532K Buy
+2,045
New +$532K 0.73% 34